Literature DB >> 30144032

Immune signalling by supramolecular assemblies.

Santosh Kumar1, Shweta Jain2.   

Abstract

Formation of supramolecular assemblies appears to be a general mechanism in immune signalling pathways. These supramolecular assemblies appear to form through a nucleated polymerization mechanism. This review examines selected immune signalling pathways that involve supramolecular assemblies, describes the concepts of protein polymerization, and discusses how those concepts of protein polymerization implicate new elegant ways for signal amplification, setting threshold and noise reduction in these pathways.
© 2018 John Wiley & Sons Ltd.

Keywords:  absent in melanoma 2-like receptors; inflammasome; killer-cell immunoglobulin-like receptor; nucleotide-binding oligomerization domain-like receptors; retinoic acid-inducible gene-I-like receptors; signalosome

Mesh:

Substances:

Year:  2018        PMID: 30144032      PMCID: PMC6231000          DOI: 10.1111/imm.12995

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  128 in total

1.  Acetylation modulates cellular distribution and DNA sensing ability of interferon-inducible protein IFI16.

Authors:  Tuo Li; Benjamin A Diner; Jin Chen; Ileana M Cristea
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-12       Impact factor: 11.205

2.  VISA is an adapter protein required for virus-triggered IFN-beta signaling.

Authors:  Liang-Guo Xu; Yan-Yi Wang; Ke-Jun Han; Lian-Yun Li; Zhonghe Zhai; Hong-Bing Shu
Journal:  Mol Cell       Date:  2005-09-16       Impact factor: 17.970

3.  T cell- and B cell-independent adaptive immunity mediated by natural killer cells.

Authors:  Jacqueline G O'Leary; Mahmoud Goodarzi; Danielle L Drayton; Ulrich H von Andrian
Journal:  Nat Immunol       Date:  2006-04-16       Impact factor: 25.606

4.  The NLRP3 inflammasome is released as a particulate danger signal that amplifies the inflammatory response.

Authors:  Alberto Baroja-Mazo; Fatima Martín-Sánchez; Ana I Gomez; Carlos M Martínez; Joaquín Amores-Iniesta; Vincent Compan; Maria Barberà-Cremades; Jordi Yagüe; Estibaliz Ruiz-Ortiz; Jordi Antón; Segundo Buján; Isabelle Couillin; David Brough; Juan I Arostegui; Pablo Pelegrín
Journal:  Nat Immunol       Date:  2014-06-22       Impact factor: 25.606

5.  An oligomeric signaling platform formed by the Toll-like receptor signal transducers MyD88 and IRAK-4.

Authors:  Precious G Motshwene; Martin C Moncrieffe; J Günter Grossmann; Cheng Kao; Murali Ayaluru; Alan M Sandercock; Carol V Robinson; Eicke Latz; Nicholas J Gay
Journal:  J Biol Chem       Date:  2009-07-10       Impact factor: 5.157

Review 6.  IRAK-4--a shared NF-kappaB activator in innate and acquired immunity.

Authors:  Nobutaka Suzuki; Takashi Saito
Journal:  Trends Immunol       Date:  2006-12       Impact factor: 16.687

Review 7.  Current prospects of type II interferon γ signaling and autoimmunity.

Authors:  Daniel S Green; Howard A Young; Julio C Valencia
Journal:  J Biol Chem       Date:  2017-06-26       Impact factor: 5.157

Review 8.  Structural mechanisms of inflammasome assembly.

Authors:  Alvin Lu; Hao Wu
Journal:  FEBS J       Date:  2014-11-21       Impact factor: 5.542

Review 9.  TNF and TNF-receptors: From mediators of cell death and inflammation to therapeutic giants - past, present and future.

Authors:  Lisa M Sedger; Michael F McDermott
Journal:  Cytokine Growth Factor Rev       Date:  2014-08-01       Impact factor: 7.638

10.  RIG-I and Other RNA Sensors in Antiviral Immunity.

Authors:  Kwan T Chow; Michael Gale; Yueh-Ming Loo
Journal:  Annu Rev Immunol       Date:  2018-04-26       Impact factor: 32.481

View more
  3 in total

1.  Paradigms for Precision Medicine in Epichaperome Cancer Therapy.

Authors:  Nagavarakishore Pillarsetty; Komal Jhaveri; Tony Taldone; Eloisi Caldas-Lopes; Blesida Punzalan; Suhasini Joshi; Alexander Bolaender; Mohammad M Uddin; Anna Rodina; Pengrong Yan; Anson Ku; Thomas Ku; Smit K Shah; Serge Lyashchenko; Eva Burnazi; Tai Wang; Nicolas Lecomte; Yelena Janjigian; Anas Younes; Connie W Batlevi; Monica L Guzman; Gail J Roboz; Jacek Koziorowski; Pat Zanzonico; Mary L Alpaugh; Adriana Corben; Shanu Modi; Larry Norton; Steven M Larson; Jason S Lewis; Gabriela Chiosis; John F Gerecitano; Mark P S Dunphy
Journal:  Cancer Cell       Date:  2019-10-24       Impact factor: 31.743

Review 2.  NLRP3 inflammasome-mediated cytokine production and pyroptosis cell death in breast cancer.

Authors:  Sara Socorro Faria; Susan Costantini; Vladmir Cláudio Cordeiro de Lima; Victor Pianna de Andrade; Mickaël Rialland; Rebe Cedric; Alfredo Budillon; Kelly Grace Magalhães
Journal:  J Biomed Sci       Date:  2021-04-12       Impact factor: 8.410

Review 3.  The role of pyroptosis and its crosstalk with immune therapy in breast cancer.

Authors:  Ling Wu; Hongsheng Lu; Yin Pan; Chen Liu; Jinyan Wang; Baofu Chen; Yichao Wang
Journal:  Front Immunol       Date:  2022-08-30       Impact factor: 8.786

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.